Publications
394
Citations
22,557
Est. group size
~30
Recurring co-author estimate
Active years
39
Publishing since 1988
Krzysztof Mrózek's research focuses on the genetics and chromosomal abnormalities underlying blood cancers, especially acute myeloid leukemia (AML) and related disorders like acute lymphoblastic leukemia. His recent work uses advanced single-cell and multiomic (combining genetic, molecular, and cellular data) techniques to track how leukemia cells evolve and diversify over time, and to identify specific gene mutations and structural changes that could serve as targets for treatment or prognosis. He also contributes to more applied, clinically oriented studies on diagnostic methods and treatment outcomes in leukemia patients.
Publication output has grown over the past decade, rising from roughly 11 papers per year in 2017 to over 20 per year in recent years, with a notable surge in 2023.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Genotype-immunophenotype relationships in <i>NPM1</i> -mutated AML clonal evolution uncovered by single-cell multiomic analysis
Blood · 2026
- Supplementary Tables from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025
- Figure 6 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025
- Figure 7 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025
- Figure 2 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025
- Figure 3 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025
- Figure 4 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025
- Supplementary Figures from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025
- Figure 5 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025
- Figure 1 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025
- Data from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025
- Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
Blood Cancer Discovery · 2025
- CRISPR/<i>Rfx</i>Cas13d Screening Identifies the Long Non-Coding RNA (LncRNA) <i>Nfyc-AS1</i> As a Molecular Vulnerability in Acute Myeloid Leukemia (AML)
Blood · 2024
- Melanoma, Cytogenetic Studies
Elsevier eBooks · 2024
- Genotype-immunophenotype relationships in <i>NPM1</i> -mutant AML clonal evolution uncovered by single cell multiomic analysis
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Blood×68
- Leukemia×19
- Blood Advances×14
- Nature Communications×5
- Nature Genetics×4
- Uma Borate
Medicine · The Ohio State University
- Alice S. Mims
Medicine · The Ohio State University
- Priyanka Mehta
Medicine · The Ohio State University
- Bhavana Bhatnagar
Medicine · The Ohio State University
- Deedra Nicolet
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile